Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
Tác giả chính: | Anderson, R |
---|---|
Tác giả khác: | Vallis, K |
Định dạng: | Luận văn |
Ngôn ngữ: | English |
Được phát hành: |
2021
|
Những chủ đề: |
Những quyển sách tương tự
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
Bằng: REN Ya'nan, et al.
Được phát hành: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
Bằng: Solmaz Mojarad-Jabali, et al.
Được phát hành: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
Bằng: P. August Schubiger, et al.
Được phát hành: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
Bằng: Paweł Szponar, et al.
Được phát hành: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Bằng: Alessio Rizzo, et al.
Được phát hành: (2022-11-01)